Tommy G. Thompson, former secretary of the U.S. Department of Health and Human Services-turned-healthcare consultant, will headline Cleveland HeartLab‘s first annual symposium on cardiovascular disease.
The symposium Where Inflammation Meets Lipids (pdf) has attracted more than a dozen thought-leaders who will speak on a range of cardiovascular disease prevention, diagnosis and management topics. The symposium will be held Aug. 14-16 at the Intercontinental Hotel on the Cleveland Clinic‘s main campus.
Thompson, an independent senior adviser for Deloitte Center for Health Solutions and partner at Washington, D.C., law firm Akin Gump Strauss Hauer & Feld, will deliver the symposium’s Aug. 16 keynote address on the future of health care. Thompson also is a former Wisconsin governor who briefly ran for U.S. president in 2008.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Launched in 2009 to commercialize a biomarker for cardiovascular inflammation discovered by the Clinic’s Dr. Stanley Hazen, Cleveland HeartLab is a clinical laboratory and disease management company offering propriety diagnostic tests to help manage cardiovascular disease.
